| Date Filed | Type | Description |
| 10/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/12/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 09/29/2023 |
4
| BENNETT C FRANK (EVP, Chief Scientific Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 4,460 shares
@ $46.5, valued at
$207.4k
|
|
| 09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
8-K
| Quarterly results |
| 09/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
8-K
| Other Events Interactive Data |
| 08/14/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/10/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/04/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 08/03/2023 |
4
| Diaz Allene M. (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 657 shares
@ $41.05, valued at
$27k
|
|
| 08/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| WENDER JOSEPH H (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| KLEIN JOSEPH III (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
|